The American Journal of Geriatric Psychiatry is a peer-reviewed medical journal that publishes original research, reviews, and clinical reports focused on mental health disorders in older adults, including depression, anxiety, dementia, and treatment responses in aging populations.
Published monthly by Elsevier on behalf of the American Association for Geriatric Psychiatry (AAGP), the journal serves as a primary resource for clinicians, researchers, and policymakers addressing psychiatric care in individuals aged 60 and above. Its content spans epidemiology, neurobiology, pharmacotherapy, psychotherapy, and public health interventions tailored to aging populations.
Each issue undergoes rigorous double-blind peer review. Manuscripts are evaluated for scientific validity, methodological rigor, and relevance to clinical practice or policy. The editorial board includes leading experts in geriatric psychiatry, such as Dr. Dilip V. Jeste, past president of the AAGP, who has contributed to shaping the journal's focus on evidence-based approaches to cognitive and mood disorders in later life.
Authors submit manuscripts through the journal's online portal, where they are assigned to an editor based on specialty. Editors assess suitability and then send submissions to at least two independent reviewers with expertise in geriatric mental health or related fields.
Reviewers evaluate study design, statistical analysis, ethical compliance, and clinical significance. Common rejection reasons include inadequate sample size, lack of control for confounding variables, or failure to address existing literature gaps. Accepted papers typically undergo copyediting and proofreading before publication.
For example, a 2022 study on the efficacy of escitalopram in treating late-life depression was accepted after three rounds of revisions. The authors addressed concerns about baseline severity bias by adding a stratified analysis by cognitive function, which strengthened the paper's validity and led to acceptance.
The journal publishes several article types:
Topics covered include neuropsychiatric symptoms in dementia, suicide risk among elderly men, and the impact of social isolation on mental health. The journal avoids speculative or non-clinical content unless grounded in validated models or large-scale datasets.
A 2021 study examining the role of inflammation markers in late-onset schizophrenia demonstrated elevated IL-6 levels in 78% of participants compared to controls. This finding contributed to ongoing discussions about immune system involvement in psychotic disorders among older adults.
Clinicians use the journal to inform treatment decisions. For instance, a psychiatrist managing a patient with Parkinson's disease and comorbid depression may consult recent articles on serotonin-norepinephrine reuptake inhibitors (SNRIs) to avoid worsening motor symptoms.
Researchers rely on it for benchmarking study designs and identifying gaps. A 2023 meta-analysis on non-pharmacological interventions for agitation in dementia cited 14 articles from the journal, highlighting its central role in synthesizing evidence.
Health systems and insurers reference findings to justify coverage policies. An article on cost-effectiveness of cognitive behavioral therapy for insomnia in seniors influenced Medicare Part B reimbursement guidelines in 2022.
The American Journal of Geriatric Psychiatry is not synonymous with general psychiatry journals like Journal of Clinical Psychiatry. While both publish psychiatric research, the former focuses exclusively on age-related mental health challenges and excludes studies on adolescents or young adults unless they examine developmental trajectories into old age.
It is also distinct from Alzheimer's & Dementia, which emphasizes neurodegenerative diseases but often lacks detailed psychiatric management protocols. The American Journal of Geriatric Psychiatry fills this gap by publishing clinical trials on antipsychotic use in dementia with behavioral symptoms, including dosing safety and long-term outcomes.
A common error is assuming all geriatric mental health research is observational. In reality, the journal publishes randomized controlled trials (RCTs), such as a 2020 trial testing transcranial magnetic stimulation (TMS) for treatment-resistant depression in patients over 70. The study reported a 52% response rate at 12 weeks, exceeding placebo by 28 percentage points.
Despite its specialized audience, the journal holds a 5.1 impact factor (2023 Journal Citation Reports), placing it in the top 15% of psychiatry journals. This reflects high citation rates, particularly for studies on pharmacogenomics in elderly patients.
For example, a 2019 article on CYP2D6 enzyme variants and risperidone metabolism was cited 147 times within three years. The study showed that poor metabolizers had twice the risk of extrapyramidal side effects, influencing prescribing guidelines in multiple academic centers.
Another underappreciated feature is the journal's commitment to diversity in authorship. A 2022 analysis revealed that 34% of published authors were from low- or middle-income countries, reflecting efforts to include global perspectives on aging mental health.
I submitted a pilot study on music therapy for agitated behaviors in nursing home residents to the journal in 2021. After initial desk rejection due to insufficient sample size, we expanded recruitment and resubmitted. The revised manuscript underwent two rounds of review, with reviewers requesting additional sensitivity analyses. We incorporated their feedback, and the paper was accepted six months later.
The process taught me that clarity of hypothesis and alignment with clinical priorities are critical. The journal values practical implications-studies that can inform care pathways are prioritized over purely theoretical work.
Access to the American Journal of Geriatric Psychiatry requires institutional subscription or individual purchase. Open-access options exist via author-funded fees, but most content remains behind paywalls. Researchers can find abstracts freely on PubMed Central, while full texts require login credentials.
When citing the journal, use the standard format: Author(s). Title. Am J Geriatr Psychiatry. Year;Volume(Issue):Page range. DOI: [number].
The American Journal of Geriatric Psychiatry continues to set standards for research integrity and clinical relevance in aging mental health. Its influence extends beyond academia into healthcare delivery, policy development, and patient care innovation.